APPLICATION FOR PRICE REVISION OF LOCAL DRUGS
NAME OF COMPANY / FIRM: _____________________________
ADDRESS: _______________________________________________
__________________________________________________________
(Please supply in duplicate)
I.
III.
V.
VII.
IX.
XI.
XIII.
XV.
1.000
Name of Product……………………………….
Registration No…………………………………
Composition…………………………………….
Initial MRP with Pack size ……………………..
Revised MRP with Pack size …………………..
Country of original patent ………………………
Date of patent registration………………………
Demanded MRP with pack size………………...
II.
IV.
VI.
VIII.
X.
XII.
XIV.
Details of Costing:
Projected
Unit Pack
Cost
Col.1
1. 100
1.200
Generic Name…………………………….
Date of Registration………………………
Pharmacological Group…………………..
Date of Price Fixation…………………….
Date of last price Revision………………..
Patent No………………………………….
Date of expiry of patent…………………..
Col.2
Cost of Raw Material(s) (See Note.1)
1.110 Active Ingredient(s)
(i)
(ii)
(iii)
(iv)
Total cost 1.110
1.120 Inactive Ingredient(s)
(i)
(ii)
(iii)
(iv)
Total 1.120
Total 1.110 + 1.120
Cost of Packing Material
1.210 Cost of Bottle, Vial, Amp.
or
Strip etc.
1.220 Cost of Inner Packing
including
label / inserts etc.
(i)
(ii)
(iii)
1.230
Cost of Outer Packing.
(i)
(ii)
(iii)
Total 1.210 + 1.220 + 1.230
Col.3
Actual for the last Financial
Year
/
Unit Pack
Cost
Total
Cost
Col.4
Col.5
Total Cost
(Col.5) as % of
Total as per
Accounts.
Col.6
%
%
%
-
%
-:2:Col.1
1.300
1.400
Col.2
Manufacturing Cost (See Note 2)
1.310 Quality Control cost
1.320 Production Cost
Total 1.310 + 1.320
Wastage during production (%)
1.500
2.000
Total 1.100 + 1.200 + 1.300 + 1.400
Sales Data (see Note 3)
2.100
Sales (This Product)
2.200
Sales this product in different pack
(i)
Col.3
Col.4
Col.5
Col.6
%
%
Quantity Sold
Unit Pack
Proposed
Price
Existing
Unit Pack
Price
Total Sale
this Product
(ii)
(iii)
(iv)
3.000
3.100
Sale (this drug) in various packing and preparation during last three years.
20
/
20
20
Sale in Value
(i)
(ii)
(iii)
3.200
Sale in Quantity
(i)
(ii)
(iii)
/
20
20
/
20
Contd….P/3
-:3:-
4.100
MANUFACTURING AND PACKING OVERHEADS FOR THIS PRODUCT.
ACTUAL OF LAST FINANCIAL YEAR
/
.
Number
of
Batches
Standard
Size of
the Batch
Yield
Obtained
Standard Labour
Hours Per Batch
Actual Labour
Hours
Labour Rate
Charged per Hour
Overhead Rate
Charged per Hour
Mfg.
Mfg.
Mfg.
Mfg.
Packing
Packing
Packing
Packing
(i)
(ii)
(iii)
4.200
FOR REST OF THE PRODUCTION:
i)
ii)
5.000
Total Manufacturing Hours Charged.
Total Packing Hours Charged.
TOTAL CAPACITY UTILIZATION FOR FINANCIAL YEAR
5.100
5.200
Days Worked
i)
Single Shift
ii)
Double Shift
iii)
Three Shift
/
.
Days
Days
Days
DIRECT LABOUR DATA FOR FINANCIAL YEAR______________.
MANUFACTURING
Number
i)
Supervisors
ii)
Workers
Cost
PACKING
Number
Cost
Contd….P/4
-:4:-
6.000
In Case Imported Materials Are Used, The Following Information May Be Provided: (See Note 4).
6.100
Materials purchased from Principal / Associated Companies.
Ingredient(s)/
Material
6.100
Active
Ingredients
(i)
(ii)
(iii)
6.120
Additives/
Inactive
Ingredients
(i)
(ii)
(iii)
6.130
Packing
Materials
(i)
(ii)
(iii)
Country of
Import
Measuring
Unit
Unit
Rate of
Exchange
Cost
C&F in F.
Currency
Landed cost
in Pack
Rupees
Consumption Per
Unit Pack
Qty.
Cost
Opening
Inventory
(Qty)
Imports during last
financial year
Total
Quantity
Total Value
Closing
Inventory
(Qty)
-:5:-
6.200
Materials purchased from others suppliers: -
6.210
Active
Ingredients
(i)
(ii)
(iii)
6.220
Additives/
Inactive
Ingredients
(i)
(ii)
(iii)
6.230
Packing
Materials
(i)
(ii)
(iii)
Contd….P/5
-:6:7.000
Prices and composition of exactly
same products available from other source i.e.
M.R.P per Unit
7.100 Local
Manufacture:
7.200
8.000
Name of Drug.
(i)
(ii)
(iii)
Import
Name of Drug
(i)
(ii)
(iii)
Prices and composition of same formulation:
Composition
8.100 Local
Manufacture:
Name of Drug.
(i)
(ii)
(iii)
8.200
Daily cost of treatment
Import
Name of Drug.
(i)
(ii)
(iii)
Pack Size
(See Note 5)
M.R.P.
Daily cost of treatment
-: 7 :9.000
Date of establishment of unit.
10.000
Initial Paid up Capital.
11.000
Financial position of last three years as per
balance sheets (please enclose copies of
audited accounts).
Year
Investment
12.000
Research expenditure for research on basic manufacture of medicines in Pakistan by the company during last three
years.
Year
Research Expenditure
Detail of chemicals / intermediate developed or
(Rupees)
under development
20
20
20
13.000
Detail of Exports Sales (if any).
13.100
13.110
13.120
13.130
14.000
Annual turnover
Status of
Exporter
Profit Before Tax
%age of
% age of
Investment
turnover
Country
Medicines
Licensed Manufacturer.
Whole Saler.
Others
Arguments in support of the request for the demanded price.
Amount remitted
In foreign exchange as
technical fee and
Royalty etc
Export Quantity
Dividends paid
Export Value
-: 8 :-
Note 1.
(a)
(b)
(c)
Note 3.
(d)
(a)
(b)
(a)
Note 4.
(b)
(a)
Note 2.
(b)
Note 5.
The actual unit cost in col.4 is to be given in case of the drug already being produced and it should be
comptetive.
Information in Col. No. 6 for Raw Material consumed for this drug as a percentage to total raw material
consumed is to be given and not for individual items.
Percentage of packing material consumed for this drug to total packing material consumed during the year is
to be given only.
In case of new company column 5 will show estimated total cost for the year.
Manufacturing cost should be competetive.
In case of new company column 5 will show estimated cost for the year.
Existing unit pack price is to be given if drug / medicine is already under production and a new price is
demanded.
Information under 2.200 is to cover different preparation of the same drug i.e. tablets, syrup etc.
Enclose invoices in support of given C&F value and indicate on invoices the date and rate of foreign
exchange against Pak. Rupee.
In case of material imported on the basis of currency other than that of the country of export, the reason be
given.
Name of the drug applied for price revision should be given first followed by other drugs. It would be helpful
if comparison is made in tabulated form to facilitate comparison.
( In case the space is insufficient to fill up proper information, plain sheets can be used).